InsiderSignal.AI

InsiderSignal.ai

QDEL - Quidelortho Corp

Insider Purchase by Blaser Brian J. (Pres, CEO)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

3 months ago, Blaser Brian J., serving as Pres, CEO at Quidelortho Corp (QDEL), purchased 23,500 shares at $21.34 per share, for a total transaction value of $501,577.00. Following this transaction, Blaser Brian J. now holds 40,984 shares of QDEL.

This purchase represents a 134.00% increase in Blaser Brian J.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, November 19, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, November 20, 2025, 1 day after the trade was made.

Quidelortho Corp operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Blaser Brian J

Blaser Brian J.

Pres, CEO

Brian J. Blaser is the President and Chief Executive Officer of QuidelOrtho Corporation (QDEL), a position he assumed on May 6, 2024, along with joining the company's Board of Directors.[[1]](https://www.quidelortho.com/us/en/resources/press-releases/quidelortho-appoints-brian-j-blaser-as-president-and-chief-executive-officer)[[2]](https://www.pathologyinpractice.com/story/44752/quidelortho-appoints-brian-blaser-as-president-and-ceo)[[3]](https://www.jhconline.com/quidelortho-appoints-brian-j-blaser-as-president-and-chief-executive-officer.html)[[7]](https://content.edgar-online.com/ExternalLink/EDGAR/0001906324-24-000025.html?hash=cbc3f0d2eeca181086680f5a39e472b0126dccab5a5237b1bbaf9d1de3d7815f&dest=qdel-20240501_htm) With over 25 years of senior leadership in the in-vitro diagnostics industry, Blaser most recently served as Executive Vice President, Diagnostic Products at Abbott Laboratories, overseeing the global diagnostics organization including core laboratory, point of care, rapid diagnostics, and molecular diagnostics businesses for seven years.[[1]](https://www.quidelortho.com/us/en/resources/press-releases/quidelortho-appoints-brian-j-blaser-as-president-and-chief-executive-officer)[[2]](https://www.pathologyinpractice.com/story/44752/quidelortho-appoints-brian-blaser-as-president-and-ceo)[[3]](https://www.jhconline.com/quidelortho-appoints-brian-j-blaser-as-president-and-chief-executive-officer.html)[[4]](https://www.medtechdive.com/news/quidelortho-brian-blaser-ceo-diagnostics/715071/) Prior roles include various strategic and operational positions at Abbott, as well as leadership at the Ortho Clinical Diagnostics division of Johnson & Johnson, Eastman Kodak, and General Motors.[[1]](https://www.quidelortho.com/us/en/resources/press-releases/quidelortho-appoints-brian-j-blaser-as-president-and-chief-executive-officer)[[2]](https://www.pathologyinpractice.com/story/44752/quidelortho-appoints-brian-blaser-as-president-and-ceo)[[3]](https://www.jhconline.com/quidelortho-appoints-brian-j-blaser-as-president-and-chief-executive-officer.html) Blaser holds an MBA with a concentration in Finance from the Rochester Institute of Technology and a Bachelor of Science in Mechanical Engineering Technology from the University of Dayton.[[1]](https://www.quidelortho.com/us/en/resources/press-releases/quidelortho-appoints-brian-j-blaser-as-president-and-chief-executive-officer)[[3]](https://www.jhconline.com/quidelortho-appoints-brian-j-blaser-as-president-and-chief-executive-officer.html) After retiring from Abbott, he served as an executive adviser at Water Street Healthcare Partners, chaired the audit committee at Rockley Photonics, and joined the board of Quanterix.[[4]](https://www.medtechdive.com/news/quidelortho-brian-blaser-ceo-diagnostics/715071/) He is actively involved in industry and community organizations, including as Advisory Council Chair of the University of Dayton School of Engineering and Chairman of the Board of Trustees for Cristo-Rey St. Martin College Prep.[[1]](https://www.quidelortho.com/us/en/resources/press-releases/quidelortho-appoints-brian-j-blaser-as-president-and-chief-executive-officer)[[3]](https://www.jhconline.com/quidelortho-appoints-brian-j-blaser-as-president-and-chief-executive-officer.html)

View full insider profile →

Trade Price

$21.34

Quantity

23,500

Total Value

$501,577.00

Shares Owned

40,984

Trade Date

Wednesday, November 19, 2025

95 days ago

SEC Filing Date

Thursday, November 20, 2025

Filed 1 day after trade

HEALTHCAREMEDICAL DEVICES

About Quidelortho Corp

Company Overview

No company information available
View news mentioning QDEL

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/1297953

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime